arrow
M

Mário Miguel Rosa

unidade local de saúde de santa maria
H指数:36
被引数:5,857

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Substantia Nigra Neuromelanin Magnetic Resonance Imaging in LRRK2 Asymptomatic Carriers

黑质神经黑色素磁共振成像在LRRK2无症状携带者中的研究

2026-05-200
PRE
Novel approaches to the stratified management of knee osteoarthritis

分层管理膝关节骨关节炎的新方法

2025-10-030
PRE
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

骨转换标志物在骨质疏松症诊断和管理中的作用的更新: 欧洲骨质疏松症,骨关节炎和肌肉骨骼疾病临床和经济方面学会 (ESCEO),国际骨质疏松症基金会 (IOF) 和国际临床化学和实验室医学联合会 (IFCC) 的共识论文

2025-03-281
OA
Impact of dementia and mild cognitive impairment on bone health in older people
2024-12-270
OAAI
Evidence-Based Guideline for the management of osteoporosis in men

男性骨质疏松症管理的循证指南

2024-03-1412
OA
Long-term follow-up of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease: An analysis of survival and disability milestones
2024-01-013
OAAI
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
2022-10-2651
OAAI
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia
2022-04-2858
OA
Management of patients at very high risk of osteoporotic fractures through sequential treatments

通过序贯治疗对骨质疏松性骨折风险极高的患者进行管理

2022-03-2468
OAAI
Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults

ESCEO关于进行旨在治疗老年人肌肉减少症的药物临床试验的建议的更新

2020-07-3152
OAAI